New Delhi: After the tragic deaths of six children in the CHINDWARA district in Madhya Pradesh before the acute kidney failure, the Ministry of Health of the Union launched a comprehensive investigation by more agencies. The team was deployed from the National Disease Control Center (NCDC), said officials who introduced this matter.
Health officials strongly suspect that contaminated syrup coughs are responsible for death. Preliminary reports suggest that an over -the -counter drug could have been defiled by diethylene glycol (DEG), which is a highly toxic chemical that is known to cause serious kidney damage. The aim of a quick reaction of the government is to determine the exact cause and stop other tragedies.
The crisis came to light after the first case was recorded on August 24, with the first death occurred on September 7. All victims, suffering from fever and cold, have developed renal failure after consuming the drug.
In response to a growing alarm, the district collector of Chhindware Sheelendra Singh, immediately banned the sale of two specific cough syrups, which are assumed to be associated with deaths.
The central government probe is in full swing. According to the official, “to exclude the possibility of any infectious disease, various samples such as water, entomological and drugs, test different agencies.”
The state drug office is now analyzing drug samples and the results are still expected, another official said quickly. In addition, Virology in Pune was sent blood samples from disabled children and the Indian Council for Medical Research (ICMR) in Delhi was brought to help investigate.
Questions sent to the Ministry of Health remained unanswered, while Madhya Pradesh could not be achieved immediately.
This tragic incident emphasizes serious public health concerns about the quality of medicinal products, especially easily available products over -the -counter. The presence of toxic substances such as Deg or ethylene glycol (EG) in routine medicine is a significant risk, especially for vulnerable children.
This is not an isolated event. Indian cough syrups were associated with similar international tragedies. In 2022, approximately 70 children in Gambia died after consuming syrups made by the Indian company Maiden Pharmaceuticals. Later in the same year and at the beginning of 2023, the death of at least 20 children in Uzbekistan was associated with the dock-1 Max, another Indian syrup produced by the Indian cough produced by Marion Biotech.
The World Health Organization (WHO) has issued a warning in both international cases, confirming that syrups contained unacceptable levels of toxic contaminants. This recurring formula raises serious questions about the production procedures and quality standards in the Indian pharmaceutical industry, often referred to as the “pharmacy of the world”.
(Tagstotranslate) Madhya Pradesh
